Ultragenyx

Showing 2 posts of 2 posts found.

novartis_window

Novartis snaps up Priority Review Voucher for $130m

December 18, 2017
Manufacturing and Production, Sales and Marketing Novartis, Ultragenyx, biotech, drugs, pharma, pharmaceutical

Novartis has got its wallet out to pick up a Priority Review Voucher (PRV) from Ultragenyx, forking out $130 million …

anatomical-2261006_960_720

Ultragenyx stumbles in P3 trial for severe muscle disease

August 23, 2017
Research and Development Ultragenyx, biotech, drugs, pharma, pharmaceutical

Ultragenyx has revealed results from a Phase 3 trial into the treatment of GNE myopathy showed that its compound did …

Latest content